Literature DB >> 9036954

Monoclonal antibodies specific for beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of scid mice reconstituted with CD45RBhigh CD4+ T cells.

D Picarella1, P Hurlbut, J Rottman, X Shi, E Butcher, D J Ringler.   

Abstract

Mucosal addressin cell adhesion molecule-1 (MAdCAM-1) is an adhesion protein expressed on endothelium in mucosal tissues that has been shown to play an important role in the selective homing of lymphocytes to intestinal mucosa and associated lymphoid tissue. To determine whether MAdCAM-1 or its ligand alpha 4 beta 7 would be appropriate targets for therapeutic intervention in gut-associated inflammation, we tested the ability of rat mAbs specific for beta 7 integrin and MAdCAM-1 to inhibit chronic colonic inflammation in scid mice reconstituted with CD4+ T cells enriched for the CD45RBhigh subpopulation. Abs specific for beta 7 and MAdCAM-1 blocked recruitment of lymphocytes to the colitic colon, and more importantly, these Abs significantly reduced the severity of colonic inflammatory disease in this animal model. Therefore, the adhesive interactions mediated by alpha 4 beta 7 and MAdCAM are intimately involved in leukocyte recruitment to gut in chronic inflammatory disease and may be relevant therapeutic targets for patients with inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9036954

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  84 in total

Review 1.  Molecules controlling lymphocyte migration to the gut.

Authors:  M Salmi; S Jalkanen
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

2.  Beta7 integrin deficiency suppresses B cell homing and attenuates chronic ileitis in SAMP1/YitFc mice.

Authors:  Gezahegn Gorfu; Jesus Rivera-Nieves; Sharon Hoang; Derek W Abbott; Keely Arbenz-Smith; David W Azar; Theresa T Pizarro; Fabio Cominelli; Marcia McDuffie; Klaus Ley
Journal:  J Immunol       Date:  2010-10-06       Impact factor: 5.422

3.  Quantitative and functional characteristics of intestinal-homing memory T cells: analysis of Crohn's disease patients and healthy controls.

Authors:  A L Hart; M A Kamm; S C Knight; A J Stagg
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

Review 4.  The role of LIGHT in T cell-mediated immunity.

Authors:  Jing Wang; Yang-Xin Fu
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

5.  Impaired mitogenic response of peripheral blood T cells in ulcerative colitis is not due to apoptosis.

Authors:  M A Pérez-Machado; L M Espinosa; E J de la Madrigal; L Abreu; G M Lorente; M Alvarez-Mon
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

6.  In vivo demonstration of T lymphocyte migration and amelioration of ileitis in intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM-1.

Authors:  K Matsuzaki; Y Tsuzuki; H Matsunaga; T Inoue; J Miyazaki; R Hokari; Y Okada; A Kawaguchi; S Nagao; K Itoh; S Matsumoto; S Miura
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

7.  Skin- and gut-homing molecules on human circulating γδ T cells and their dysregulation in inflammatory bowel disease.

Authors:  E R Mann; N E McCarthy; S T C Peake; A N Milestone; H O Al-Hassi; D Bernardo; C T Tee; J Landy; M C Pitcher; S A Cochrane; A L Hart; A J Stagg; S C Knight
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

8.  Vedolizumab as a Treatment for Crohn's Disease and Ulcerative Colitis.

Authors:  Christina Ha; Asher Kornbluth
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-12

9.  Pharmacology of AMG 181, a human anti-α4 β7 antibody that specifically alters trafficking of gut-homing T cells.

Authors:  W J Pan; H Hsu; W A Rees; S P Lear; F Lee; I N Foltz; P Rathanaswami; K Manchulenko; B M Chan; M Zhang; X Z Xia; S K Patel; P J Prince; D R Doherty; C M Sheckler; K O Reynhardt; C D Krill; B J Harder; J A Wisler; J L Brandvig; J L Lynch; A A Anderson; L C Wienkers; D C Borie
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

10.  Anti-IL-6 receptor monoclonal antibody inhibits leukocyte recruitment and promotes T-cell apoptosis in a murine model of Crohn's disease.

Authors:  Hiroaki Ito; Tomonori Hirotani; Mitsunari Yamamoto; Hiroyuki Ogawa; Tadamitsu Kishimoto
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.